Industry warming to more user-friendly FDA inspections
This article was originally published in Clinica
Executive Summary
Like paying taxes, FDA plant inspections have typically been something to endure - an unpleasant but necessary burden. But a new survey conducted by an FDA/industry committee under the auspices of the Medical Device Industry Initiatives Grassroots Task Force suggests companies are changing their minds about the FDA inspection process.